We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Fraud Claims Dismissed in Suit Against InterMune
Fraud Claims Dismissed in Suit Against InterMune
November 13, 2009
A federal court has dismissed fraud claims in a class action lawsuit against InterMune that accused the drugmaker of marketing its Actiummune to treat idiopathic pulmonary fibrosis (IPF) without FDA approval of the indication.